Predicting Clinical Outcomes and Response to Thrombolysis in Acute Stroke Patients With Diabetes
Therapies Thursday, June 27th, 2013Diabetes Care: July 1, 2013
OBJECTIVE Few tools are available to evaluate clinical outcomes and response to thrombolysis (tPA) in stroke patients with diabetes. We explored how the iScore (www.sorcan.ca/iscore), a validated risk score, predicts clinical outcomes in stroke patients with and without diabetes.
RESEARCH DESIGN AND METHODS We applied the iScore to stroke patients presenting to stroke centers participating in the Registry of the Canadian Stroke Network. Main outcomes included favorable outcome, defined as a modified Rankin scale (mRS) 0–2 at discharge, and intracerebral hemorrhage (ICH) after tPA. Read More